Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(hexahydro-1h-azepin-1-yl)ethyl Alpha-cyclohexyl-3-thiopheneacetate Citrate (1:1)
2. 3-thiopheneacetic Acid, Alpha-cyclohexyl-, 2-(hexahydro-1h-azepin-1-yl)ethyl Ester, Hydrochloride (1:1)
3. Cetiedil Citrate
4. Cetiedil Citrate (1:1)
5. Cetiedil Hydrochloride
6. Cetiedil Oxalate
7. Stratene
1. Fusten
2. 14176-10-4
3. Cetiedil [inn]
4. Cetiedilum [inn-latin]
5. Einecs 238-028-2
6. Brn 1591408
7. 2-(azepan-1-yl)ethyl 2-cyclohexyl-2-thiophen-3-ylacetate
8. Chebi:34619
9. 621rt200to
10. Cetiedilum
11. Unii-621rt200to
12. 2-(1-azepanyl)ethyl 2-cyclohexyl-2-(3-thienyl)acetat
13. Cetiedil [mi]
14. Cetiedil [who-dd]
15. 2-(hexahydro-1h-azepin-1-yl)ethyl-alpha-cyclohexyl-3-thiopheneacetic Acid
16. Alpha-cyclohexyl-3-thiopheneacetic Acid, 2-(hexahydro-1h-azepin-1-yl)ethyl Ester
17. Schembl458084
18. Chembl419380
19. Dtxsid70864474
20. Db13753
21. 3-thiopheneacetic Acid, .alpha.-cyclohexyl-, 2-(hexahydro-1h-azepin-1-yl)ethyl Ester
22. 3-thiopheneacetic Acid, Alpha-cyclohexyl-, 2-(hexahydro-1h-azepin-1-yl)ethyl Ester
23. Nci60_021536
24. Q5065661
25. 2-(azepan-1-yl)ethyl 2-cyclohexyl-2-(3-thienyl)acetate
26. 2-(hexahydro-1h-azepin-1-yl)ethyl .alpha.-cyclohexyl-3-thiopheneacetate
Molecular Weight | 349.5 g/mol |
---|---|
Molecular Formula | C20H31NO2S |
XLogP3 | 5.4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 7 |
Exact Mass | 349.20755041 g/mol |
Monoisotopic Mass | 349.20755041 g/mol |
Topological Polar Surface Area | 57.8 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 376 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antisickling Agents
Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions. (See all compounds classified as Antisickling Agents.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
C - Cardiovascular system
C04 - Peripheral vasodilators
C04A - Peripheral vasodilators
C04AX - Other peripheral vasodilators
C04AX26 - Cetiedil
ABOUT THIS PAGE
A Cetiedil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cetiedil, including repackagers and relabelers. The FDA regulates Cetiedil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cetiedil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cetiedil supplier is an individual or a company that provides Cetiedil active pharmaceutical ingredient (API) or Cetiedil finished formulations upon request. The Cetiedil suppliers may include Cetiedil API manufacturers, exporters, distributors and traders.
click here to find a list of Cetiedil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cetiedil DMF (Drug Master File) is a document detailing the whole manufacturing process of Cetiedil active pharmaceutical ingredient (API) in detail. Different forms of Cetiedil DMFs exist exist since differing nations have different regulations, such as Cetiedil USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cetiedil DMF submitted to regulatory agencies in the US is known as a USDMF. Cetiedil USDMF includes data on Cetiedil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cetiedil USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cetiedil suppliers with USDMF on PharmaCompass.
Cetiedil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cetiedil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cetiedil GMP manufacturer or Cetiedil GMP API supplier for your needs.
A Cetiedil CoA (Certificate of Analysis) is a formal document that attests to Cetiedil's compliance with Cetiedil specifications and serves as a tool for batch-level quality control.
Cetiedil CoA mostly includes findings from lab analyses of a specific batch. For each Cetiedil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cetiedil may be tested according to a variety of international standards, such as European Pharmacopoeia (Cetiedil EP), Cetiedil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cetiedil USP).
LOOKING FOR A SUPPLIER?